The Independent on MSN

New blood test could show if prostate cancer treatment is failing

New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...

Prostate cancer screening through a blood test 'could reduce deaths'

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
STAT

PSA screening for prostate cancer reduces disease-specific deaths, new review shows

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
Morning Overview on MSN

A landmark review just reversed decades of recommendations on a blood test that detects a biomarker for one of the most common cancers

For more than a decade, millions of men heard the same message from their doctors: a routine PSA blood test probably was not ...

Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
Nature

Does the PSA test for prostate cancer save lives? New data reverse gold-standard findings

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
Starts at 60

PSA testing for prostate cancer does save lives, major new review finds — but there’s an important catch

A landmark review of nearly 800,000 men has found that PSA blood tests do reduce prostate cancer deaths — a shift from ...
KPLC

New test for prostate cancer may help catch it early

ORLANDO, Fla. (Ivanhoe Newswire) - Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced ...
Healio

Precision medicine navigator makes genomic testing in prostate cancer ‘100 times easier’

Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...
Nasdaq

Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...